drugset / Trial / NCT07556484
Pharmacokinetics Of Emulsified Avacopan Applied By NG Tube
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to determine the 72-hour pharmacokinetics of emulsified avacopan at a dose of 30 mg twice daily given to up to 6 patients with active severe GPA or MPA with diffuse alveolar hemorrhage (DAH) requiring mechanical ventilation for respiratory support.
Timeline
- Start
- 2026-05
- Primary completion
- 2028-03
- Completion
- 2028-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Avacopan | Small molecule | 30 mg | Other |